Biological basis of [11C]choline-positron emission tomography in patients with breast cancer: Comparison with [18F]fluorothymidine positron emission tomography

Nuclear Medicine Communications

Volumn 32, Issue 11, 2011, Pages 997-1004

  Contractor, Kaiyumars B ^a   Kenny, Laura M ^a   Stebbing, Justin ^a   Challapalli, Amarnath ^a   Al Nahhas, Adil ^a   Palmieri, Carlo ^a   Shousha, Sami ^a   Lewis, Jacqueline S ^a,b   Hogben, Katy ^a,b   De Nguyen, Quang ^a   Coombes, Raul Charles ^a   Aboagye, Eric O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

11C choline positron emission tomography; 18F fluorothymidinepositron emission tomography; breast cancer; cholinekinase a expression; proliferation

Indexed keywords

3' FLUOROTHYMIDINE F 18; BIOLOGICAL MARKER; CHOLINE C 11; CHOLINE KINASE; KI 67 ANTIGEN; CARBON; CHKA PROTEIN, HUMAN; CHOLINE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; INTERMETHOD COMPARISON; LABELING INDEX; LUNG METASTASIS; METABOLISM; POSITRON EMISSION TOMOGRAPHY; SCORING SYSTEM; STANDARD; TUMOR BIOPSY; TUMOR VOLUME; ADENOCARCINOMA; BLOOD; BREAST TUMOR; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARBON RADIOISOTOPES; CELL PROLIFERATION; CHOLINE; CHOLINE KINASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 80053573662     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328349567b     Document Type: Article

References (23)

1. Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EI, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005; 11:2785-2808. (Pubitemid 40525178)
2. Gao M, Miller MA, DeGrado TR, Mock BH, Lopshire JC, Rosenberger JG, et al. Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart. Bioorg Med Chem 2007; 15:1289-1297. (Pubitemid 46038134)
3. Ramirez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Taron M, Ramirez de Molina V, Cejas P, et al. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. Lancet Oncol 2007; 8:889-897. (Pubitemid 47488053)
4. Contractor KB, Kenny LM, Stebbing J, Al-Nahhas A, Palmieri C, Sinnett D, et al. [11C]choline positron emission tomography in estrogen receptorpositive breast cancer. Clin Cancer Res 2009; 15:5503-5510.
5. Ramirez de Molina A, Gutierrez R, Ramos MA, Silva JM, Silva J, Bonilla F, et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumour strategy. Oncogene 2002; 21:4317-4322. (Pubitemid 34753838)
6. Piert M, Park H, Khan A, Siddiqui J, Hussain H, Chenevert T, et al. Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques. J Nucl Med 2009; 50:1585-1593.
7. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 2002; 62:1966-1970. (Pubitemid 34408439)
8. Al-Saeedi F, Welch AE, Smith TA. [Methyl-3H]choline incorporation into MCF7 tumour cells: correlation with proliferation. Eur J Nucl Med Mol Imaging 2005; 32:660-667. (Pubitemid 40897488)
9. Breeuwsma AJ, Pruim J, Jongen MM, Suurmeijer AJ, Vaalburg W, Nijman RJ, et al. In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging 2005; 32:668-673. (Pubitemid 40897489)
10. Kenny LM, Vigushin DM, Al-Nahhas A, Osman S, Luthra SK, Shousha S, et al. Quantification of cellular proliferation in tumour and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res 2005; 65:10104-10112. (Pubitemid 41541493)
11. Claudio Pascali AB, Itawa R, Cambiè M, Bombardieri E. [11C]methylation on a C18 Sep-Pak cartridge: a convenient way to produce [Nmethyl-11C]choline. J Labelled Compds Radiopharm 2000; 43:195-203. (Pubitemid 30072211)
12. Wodarski C, Eisenbarth J, Weber K, Henze M, Haberkorn U, Eisenhut M. Synthesis of 3-deoxy-3-[18F]fluoro-thymidine with 2,3-anhydro-5-O-(4, 4-dimethoxytrityl)-thymidine. J Labelled Compds Radiopharm 2000; 43:1211-1218.
13. Lucignani G, Paganelli G, Bombardieri E. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective. Nucl Med Commun 2004; 25:651-656. (Pubitemid 38901681)
14. Mankoff DA, Shields AF, Graham MM, Link JM, Krohn KA. A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites. J Nucl Med 1996; 37:2049-2057. (Pubitemid 26428380)
15. Bilous AM, McKay M, Milliken J. A comparison between Ki-67 antibody reactivity and other pathological variables in breast carcinoma. Pathology 1991; 23:282-285.
16. Michel V, Yuan Z, Ramsubir S, Bakovic M. Choline transport for phospholipid synthesis. Exp Biol Med (Maywood) 2006; 231:490-504.
17. Glunde K, Raman V, Mori N, Bhujwalla ZM. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res 2005; 65:11034-11043. (Pubitemid 41713374)
18. Liu D, Hutchinson OC, Osman S, Price P, Workman P, Aboagye EO. Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin. Br J Cancer 2002; 87:783-789. (Pubitemid 35178757)
19. Choi MG, Park TS, Carman GM. Phosphorylation of Saccharomyces cerevisiae CTP synthetase at Ser424 by protein kinases A and C regulates phosphatidylcholine synthesis by the CDP-choline pathway. J Biol Chem 2003; 278:23610-23616. (Pubitemid 36830182)
20. Ratnam S, Kent C. Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys 1995; 323:313-322.
21. Hernandez-Alcoceba R, Fernandez F, Lacal JC. In vivo antitumour activity of choline kinase inhibitors: a novel target for anticancer drug discovery. Cancer Res 1999; 59:3112-3118. (Pubitemid 29316010)
22. Yu Y, Sreenivas A, Ostrander DB, Carman GM. Phosphorylation of Saccharomyces cerevisiae choline kinase on Ser30 and Ser85 by protein kinase A regulates phosphatidylcholine synthesis by the CDP-choline pathway. J Biol Chem 2002; 277:34978-34986.
23. Shields AF, Lawhorn-Crews JM, Briston DA, Zalzala S, Gadgeel S, Douglas KA, et al. Analysis and reproducibility of 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer. Clin Cancer Res 2008; 14:4463-4468.